Conclusion This case report demonstrates that the combination of prolonged water fasting and a GLP-1 receptor agonist is a safe and effective method for short-term substantial weight loss in patients with severe obesity for the purpose of pre-procedural optimization prior to bariatric surgery, and may result in the improvement of multiple chronic diseases including hypertension, insulin resistance, anemia, depression, and diastolic heart failure
Yes, some women have reported changes in menstrual patterns, including irregular periods, heavier or lighter bleeding, or spotting, possibly related to weight loss or hormonal changes induced by semaglutide
Common causes include gallstones, heavy alcohol use, or certain medications, but in most cases related to weight loss drugs, it's mild and resolves with treatment
Your provider will determine how much and how often to adjust your medication based on your reaction and tolerance, especially if you need a higher dose
Weiss Surkhabi, a dual board-certified physician in family and obesity medicine. We started the company in early 2023 out of a shared passion to expand access to effective, compassionate weight care. Since treating the first patient in November 2023, Fridays has rapidly grown through social media education posts and word of mouth
Report adverse events to FDA MedWatch at fda.gov/medwatch or 1-800-FDA-1088.
